"Where Everyone Has an MBA"
Tel: (612) 246-4616
Frequently Asked Questions
- Frequently Asked Questions
- User Testimonials
Biomerica, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Biomerica, Inc.
Should You Worry About Biomerica, Inc.'s (NASDAQ:BMRA) CEO Pay Cheque?
- Sep 29th, 2019 1:15 pm
The MicroCap Rodeo Investor Conference - October 15 and 16, 2019, Austin Texas
- Sep 19th, 2019 2:15 pm
Does Market Volatility Impact Biomerica, Inc.'s (NASDAQ:BMRA) Share Price?
- Aug 30th, 2019 2:31 pm
Biomerica Announces Fiscal Year End 2019 Financial Results
- Aug 30th, 2019 12:30 pm
Republic of Colombia’s food and drug regulatory agency grants clearance for Biomerica’s colorectal cancer screening test to be sold in Colombia
- Aug 21st, 2019 12:19 pm
When Can We Expect A Profit From Biomerica, Inc. (NASDAQ:BMRA)?
- Jul 25th, 2019 3:33 pm
Can You Imagine How Chuffed Biomerica's (NASDAQ:BMRA) Shareholders Feel About Its 141% Share Price Gain?
- Jun 19th, 2019 6:28 pm
Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million.
- Jun 5th, 2019 12:19 pm
Could Biomerica, Inc.'s (NASDAQ:BMRA) Investor Composition Influence The Stock Price?
- Apr 25th, 2019 2:06 pm
BMRA: Revenue Slows Although Potential Growth Catalysts on the Horizon. Further Pipeline Progress
- Apr 22nd, 2019 3:00 pm
Biomerica Announces Third Quarter Financial Results
- Apr 16th, 2019 1:18 pm
Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS)
- Apr 8th, 2019 12:19 pm
LD Micro Virtual Conference Is Live, March 12th and 13th
- Mar 12th, 2019 12:45 pm
What You Must Know About Biomerica, Inc.’s (NASDAQ:BMRA) Beta Value
- Feb 21st, 2019 7:49 pm
Biomerica Announces Updates for H. Pylori Clinical Studies
- Feb 5th, 2019 1:19 pm
An Intrinsic Calculation For Biomerica, Inc. (NASDAQ:BMRA) Shows It’s 32.14% Undervalued
- Jan 22nd, 2019 7:42 pm
BMRA: Q2’19 Results: Asia Continues to Accelerate, Europe Rebounds, U.S. Still Weak But Could Return to Growth
- Jan 21st, 2019 4:00 pm
Biomerica Announces Second Quarter Financial Results
- Jan 15th, 2019 1:19 pm
Medline and Biomerica sign agreement for distribution of Biomerica’s colorectal screening test to help identify an early warning sign of colorectal cancer
- Nov 28th, 2018 1:19 pm
Consolidated Research: 2018 Summary Expectations for ProQR Therapeutics N.V, Biomerica, VEREIT, Apergy, Zendesk, and Arcus Biosciences — Fundamental Analysis, Key Performance Indications
- Nov 16th, 2018 1:55 pm
Frequently Asked Questions
Terms and Conditions
Copyright © 2019 VentureLine
Website developed by Digital Solutions